Incidental Mutation 'R7764:Sart1'
ID 598155
Institutional Source Beutler Lab
Gene Symbol Sart1
Ensembl Gene ENSMUSG00000039148
Gene Name squamous cell carcinoma antigen recognized by T cells 1
Synonyms U5-110K
MMRRC Submission 045820-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R7764 (G1)
Quality Score 225.009
Status Not validated
Chromosome 19
Chromosomal Location 5427551-5438731 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to A at 5438613 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Glycine to Tryptophan at position 15 (G15W)
Ref Sequence ENSEMBL: ENSMUSP00000047397 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000044207] [ENSMUST00000044527]
AlphaFold Q9Z315
Predicted Effect probably damaging
Transcript: ENSMUST00000044207
AA Change: G15W

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000047397
Gene: ENSMUSG00000039148
AA Change: G15W

DomainStartEndE-ValueType
low complexity region 13 26 N/A INTRINSIC
low complexity region 31 83 N/A INTRINSIC
Pfam:SART-1 117 759 1.5e-151 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000044527
SMART Domains Protein: ENSMUSP00000047408
Gene: ENSMUSG00000039330

DomainStartEndE-ValueType
low complexity region 1 16 N/A INTRINSIC
coiled coil region 33 63 N/A INTRINSIC
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 100.0%
  • 10x: 99.8%
  • 20x: 99.3%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway. [provided by RefSeq, Jul 2008]
Allele List at MGI
Other mutations in this stock
Total: 59 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abcf3 T G 16: 20,368,040 (GRCm39) L93V probably benign Het
Adss2 A C 1: 177,591,827 (GRCm39) M452R probably damaging Het
Aldh3b1 T A 19: 3,971,563 (GRCm39) K102* probably null Het
Ccdc162 A T 10: 41,566,109 (GRCm39) V78D possibly damaging Het
Ccr3 T C 9: 123,829,451 (GRCm39) V262A probably benign Het
Cdk13 A T 13: 17,895,890 (GRCm39) probably null Het
Cdyl A T 13: 36,000,126 (GRCm39) T136S possibly damaging Het
Chd2 T C 7: 73,121,567 (GRCm39) D1015G probably null Het
Cntn2 C A 1: 132,450,101 (GRCm39) A598S probably benign Het
Cxxc4 G T 3: 133,945,856 (GRCm39) G146C unknown Het
Dnah2 G A 11: 69,348,984 (GRCm39) T2501I probably benign Het
Dock8 T A 19: 25,074,899 (GRCm39) I471N probably benign Het
Eaf2 A G 16: 36,645,045 (GRCm39) V59A probably damaging Het
Egflam T A 15: 7,347,736 (GRCm39) I65F probably damaging Het
Exoc3l A G 8: 106,017,333 (GRCm39) V577A possibly damaging Het
Folh1 A T 7: 86,412,126 (GRCm39) M215K probably benign Het
Fosb T C 7: 19,038,971 (GRCm39) D271G possibly damaging Het
Frmd4b A G 6: 97,272,891 (GRCm39) Y834H probably damaging Het
Fsip2 T C 2: 82,811,252 (GRCm39) S2524P possibly damaging Het
Gbp3 A G 3: 142,271,024 (GRCm39) T143A probably benign Het
Grk2 A T 19: 4,337,391 (GRCm39) L632Q probably damaging Het
Hars1 A T 18: 36,903,237 (GRCm39) D364E probably damaging Het
Hsd17b4 G T 18: 50,279,482 (GRCm39) G154* probably null Het
Kif5c T C 2: 49,617,973 (GRCm39) probably null Het
Kif5c T C 2: 49,639,339 (GRCm39) L800P probably damaging Het
Krt19 T C 11: 100,032,218 (GRCm39) N282S probably benign Het
Med23 T G 10: 24,785,818 (GRCm39) probably null Het
Meltf A G 16: 31,699,085 (GRCm39) Q65R probably benign Het
Mms22l T C 4: 24,598,842 (GRCm39) S1106P probably damaging Het
Mprip A G 11: 59,655,242 (GRCm39) T733A probably damaging Het
Mul1 G A 4: 138,162,080 (GRCm39) G4S possibly damaging Het
Myl10 G C 5: 136,726,825 (GRCm39) V70L probably benign Het
Mylk G T 16: 34,742,553 (GRCm39) V1022L probably benign Het
Ncald G T 15: 37,397,454 (GRCm39) N75K probably damaging Het
Nfib A G 4: 82,238,731 (GRCm39) S492P possibly damaging Het
Notch2 A T 3: 98,050,304 (GRCm39) I1860F probably damaging Het
Or9i14 A G 19: 13,792,111 (GRCm39) I281T probably benign Het
Oxr1 T C 15: 41,683,263 (GRCm39) S298P probably benign Het
Pcnt T C 10: 76,190,082 (GRCm39) D2818G probably benign Het
Pmpcb G A 5: 21,948,450 (GRCm39) A244T probably damaging Het
Poln A G 5: 34,274,151 (GRCm39) probably null Het
Polr1a G A 6: 71,930,054 (GRCm39) V914M probably damaging Het
Rab15 A C 12: 76,851,215 (GRCm39) probably null Het
Rasgrf1 G T 9: 89,876,747 (GRCm39) S704I possibly damaging Het
Rsf1 GGCGGCGG GGCGGCGGGCGCGGCGG 7: 97,229,134 (GRCm39) probably benign Het
Scrib T C 15: 75,919,242 (GRCm39) *1666W probably null Het
Setd1b G C 5: 123,284,622 (GRCm39) R184P unknown Het
Sfxn2 A T 19: 46,574,179 (GRCm39) N123I probably damaging Het
Slc22a3 A G 17: 12,677,383 (GRCm39) W262R probably damaging Het
Slc38a10 A G 11: 119,995,905 (GRCm39) L1064P probably damaging Het
Sorcs2 A T 5: 36,181,416 (GRCm39) S1077R possibly damaging Het
Them7 G T 2: 105,128,171 (GRCm39) E51* probably null Het
Ubc A G 5: 125,465,133 (GRCm39) S65P possibly damaging Het
Ubqln3 A T 7: 103,790,443 (GRCm39) M549K possibly damaging Het
Vmn1r222 A G 13: 23,416,529 (GRCm39) L228P probably damaging Het
Vmn2r60 A G 7: 41,844,535 (GRCm39) T633A probably damaging Het
Zfp382 T C 7: 29,832,700 (GRCm39) V117A probably benign Het
Zic1 C T 9: 91,247,745 (GRCm39) probably benign Het
Zmym4 A T 4: 126,819,409 (GRCm39) F165I probably benign Het
Other mutations in Sart1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01070:Sart1 APN 19 5,433,979 (GRCm39) missense probably benign 0.00
IGL02390:Sart1 APN 19 5,430,489 (GRCm39) missense possibly damaging 0.85
IGL02533:Sart1 APN 19 5,433,749 (GRCm39) nonsense probably null
IGL03094:Sart1 APN 19 5,434,109 (GRCm39) splice site probably benign
R0219:Sart1 UTSW 19 5,438,424 (GRCm39) missense probably benign
R0226:Sart1 UTSW 19 5,431,150 (GRCm39) splice site probably benign
R0304:Sart1 UTSW 19 5,430,559 (GRCm39) splice site probably benign
R0537:Sart1 UTSW 19 5,431,752 (GRCm39) missense probably damaging 0.99
R0668:Sart1 UTSW 19 5,434,284 (GRCm39) missense probably damaging 1.00
R1574:Sart1 UTSW 19 5,430,287 (GRCm39) missense probably damaging 1.00
R1574:Sart1 UTSW 19 5,430,287 (GRCm39) missense probably damaging 1.00
R1674:Sart1 UTSW 19 5,435,853 (GRCm39) missense probably damaging 0.99
R4077:Sart1 UTSW 19 5,432,771 (GRCm39) missense possibly damaging 0.48
R4866:Sart1 UTSW 19 5,432,248 (GRCm39) missense probably damaging 1.00
R5081:Sart1 UTSW 19 5,438,576 (GRCm39) missense possibly damaging 0.72
R5523:Sart1 UTSW 19 5,433,704 (GRCm39) missense probably damaging 0.99
R5756:Sart1 UTSW 19 5,430,497 (GRCm39) missense probably damaging 1.00
R5875:Sart1 UTSW 19 5,433,823 (GRCm39) missense probably damaging 1.00
R5979:Sart1 UTSW 19 5,431,251 (GRCm39) missense probably damaging 1.00
R7360:Sart1 UTSW 19 5,433,231 (GRCm39) missense probably damaging 0.96
R7560:Sart1 UTSW 19 5,434,905 (GRCm39) missense probably damaging 0.97
R8426:Sart1 UTSW 19 5,433,769 (GRCm39) missense probably benign
R8517:Sart1 UTSW 19 5,433,225 (GRCm39) missense probably damaging 0.98
R8796:Sart1 UTSW 19 5,438,376 (GRCm39) missense probably damaging 1.00
R8927:Sart1 UTSW 19 5,438,529 (GRCm39) missense probably benign
R8928:Sart1 UTSW 19 5,438,529 (GRCm39) missense probably benign
Predicted Primers PCR Primer
(F):5'- GGACGTCTTTAACCCGAGAG -3'
(R):5'- ATCTTAGATGGCGCGAGAGG -3'

Sequencing Primer
(F):5'- GTAGCCGTCATCGCGTTTC -3'
(R):5'- AGCCTTTGGAGGTTCCCAG -3'
Posted On 2019-11-26